How reliable are tests for trachoma?--a latent class approach
- PMID: 21685340
- PMCID: PMC3176003
- DOI: 10.1167/iovs.11-7419
How reliable are tests for trachoma?--a latent class approach
Abstract
Purpose: Tests for ocular Chlamydia trachomatis have not been well characterized, because there is no gold standard test. Latent class analysis (LCA) was performed to estimate the sensitivity and specificity of laboratory and clinical tests for trachoma in the absence of a gold standard.
Methods: Individual data from pretreatment, hyperendemic areas in Ethiopia were used. A clustered LCA was performed for three diagnostic tests: PCR and WHO simplified criteria grades of follicular trachoma (TF) and intense trachomatous inflammation (TI).
Results: Data from 2111 subjects in 40 villages were available. TF was estimated to be 87.3% (95% CI, 83.3-90.1) sensitive and 36.6% (95% CI, 23.6-40.3) specific; TI was estimated to be 53.6% (95% CI, 46.1-88.0) sensitive and 88.3% (95% CI, 83.3-92.0) specific, and PCR was estimated to be 87.5% (95% CI, 79.9-97.2) sensitive and 100% (95% CI 69.3-100) specific.
Conclusions: LCA allows for an estimate of test characteristics without prior assumption of their performance. TF and TI were found to act in a complementary manner: TF is a sensitive test and TI is a specific test. PCR is highly specific but lacks sensitivity. The performance of these tests may be due to the time course of ocular chlamydial infection, and for this reason, results may differ in areas of low prevalence or recent mass treatment (ClinicalTrials.gov number, NCT00221364).
Figures


Similar articles
-
Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):235-40. doi: 10.1167/iovs.11-8493. Invest Ophthalmol Vis Sci. 2012. PMID: 22159017 Free PMC article. Clinical Trial.
-
Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.PLoS Negl Trop Dis. 2019 Jan 28;13(1):e0007127. doi: 10.1371/journal.pntd.0007127. eCollection 2019 Jan. PLoS Negl Trop Dis. 2019. PMID: 30689671 Free PMC article. Clinical Trial.
-
How reliable is the clinical exam in detecting ocular chlamydial infection?Ophthalmic Epidemiol. 2004 Jul;11(3):255-62. doi: 10.1080/09286580490514577. Ophthalmic Epidemiol. 2004. PMID: 15370556
-
Application of molecular tools in the control of blinding trachoma.Am J Trop Med Hyg. 2003 Nov;69(5 Suppl):11-7. doi: 10.4269/ajtmh.2003.69.11. Am J Trop Med Hyg. 2003. PMID: 14692675 Free PMC article. Review.
-
The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment.PLoS Negl Trop Dis. 2016 Oct 26;10(10):e0005080. doi: 10.1371/journal.pntd.0005080. eCollection 2016 Oct. PLoS Negl Trop Dis. 2016. PMID: 27783678 Free PMC article. Review.
Cited by
-
Antibiotics for trachoma.Cochrane Database Syst Rev. 2019 Sep 26;9(9):CD001860. doi: 10.1002/14651858.CD001860.pub4. Cochrane Database Syst Rev. 2019. PMID: 31554017 Free PMC article.
-
Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection.Parasit Vectors. 2015 Oct 22;8:535. doi: 10.1186/s13071-015-1115-8. Parasit Vectors. 2015. PMID: 26489933 Free PMC article.
-
Comparison of Smartphone Photography, Single-Lens Reflex Photography, and Field-Grading for Trachoma.Am J Trop Med Hyg. 2020 Dec;103(6):2488-2491. doi: 10.4269/ajtmh.20-0386. Epub 2020 Oct 1. Am J Trop Med Hyg. 2020. PMID: 33021196 Free PMC article.
-
The geographical distribution and burden of trachoma in Africa.PLoS Negl Trop Dis. 2013 Aug 8;7(8):e2359. doi: 10.1371/journal.pntd.0002359. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 23951378 Free PMC article.
-
CT694 and pgp3 as serological tools for monitoring trachoma programs.PLoS Negl Trop Dis. 2012;6(11):e1873. doi: 10.1371/journal.pntd.0001873. Epub 2012 Nov 1. PLoS Negl Trop Dis. 2012. PMID: 23133684 Free PMC article.
References
-
- Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet. 1999;354(9179):630–635 - PubMed
-
- World Health Organization Report of the Eighth Meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma. Geneva, WHO; 2004
-
- Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med. 1999;5(5):572–576 - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous